250 related articles for article (PubMed ID: 20700123)
1. miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC).
Kikkawa N; Hanazawa T; Fujimura L; Nohata N; Suzuki H; Chazono H; Sakurai D; Horiguchi S; Okamoto Y; Seki N
Br J Cancer; 2010 Sep; 103(6):877-84. PubMed ID: 20700123
[TBL] [Abstract][Full Text] [Related]
2. Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature.
Fukumoto I; Kinoshita T; Hanazawa T; Kikkawa N; Chiyomaru T; Enokida H; Yamamoto N; Goto Y; Nishikawa R; Nakagawa M; Okamoto Y; Seki N
Br J Cancer; 2014 Jul; 111(2):386-94. PubMed ID: 24918822
[TBL] [Abstract][Full Text] [Related]
3. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
Kikkawa N; Kinoshita T; Nohata N; Hanazawa T; Yamamoto N; Fukumoto I; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
Int J Oncol; 2014 Jun; 44(6):2085-92. PubMed ID: 24647829
[TBL] [Abstract][Full Text] [Related]
4. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
Nohata N; Hanazawa T; Kinoshita T; Inamine A; Kikkawa N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
Br J Cancer; 2013 Apr; 108(8):1648-58. PubMed ID: 23558898
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
Liu X; Zhao W; Wang X
Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
[TBL] [Abstract][Full Text] [Related]
6. lncRNA HOXA11-AS Promotes Proliferation and Migration via Sponging miR-155 in Hypopharyngeal Squamous Cell Carcinoma.
Xu J; Bo Q; Zhang X; Lei D; Wang J; Pan X
Oncol Res; 2020 May; 28(3):311-319. PubMed ID: 31987067
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
8. Aberrant GRK6 promoter methylation is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.
Qiu X; Chen J; Zhang Z; You Y; Wang Z
Oncol Rep; 2016 Feb; 35(2):1027-33. PubMed ID: 26718636
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Sakurai D; Fujimura L; Kawakami K; Chiyomaru T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
J Hum Genet; 2011 Aug; 56(8):595-601. PubMed ID: 21753766
[TBL] [Abstract][Full Text] [Related]
10. Novel circular RNA expression profiles reflect progression of patients with hypopharyngeal squamous cell carcinoma.
Cao S; Wei D; Li X; Zhou J; Li W; Qian Y; Wang Z; Li G; Pan X; Lei D
Oncotarget; 2017 Jul; 8(28):45367-45379. PubMed ID: 28514762
[TBL] [Abstract][Full Text] [Related]
11. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
12. A 3-miRNA signature predicts survival of patients with hypopharyngeal squamous cell carcinoma after post-operative radiotherapy.
Xu X; Lu Z; Gross N; Li G; Zhang F; Lei D; Pan X
J Cell Mol Med; 2019 Dec; 23(12):8280-8291. PubMed ID: 31578816
[TBL] [Abstract][Full Text] [Related]
13. Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications.
Sasaki CT; Doukas SG; Costa J; Vageli DP
Cancer; 2019 Oct; 125(20):3554-3565. PubMed ID: 31310330
[TBL] [Abstract][Full Text] [Related]
14. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of BTF3 affects the proliferation, apoptosis, and cell cycle regulation in hypopharyngeal squamous cell carcinoma.
Zhang Y; Gross N; Li Z; Yin G; Zhong Q; Liu C; Huang Z
Biomed Pharmacother; 2019 Oct; 118():109211. PubMed ID: 31404775
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of different mRNA and miRNA profiles in human hypopharyngeal squamous cell carcinoma sensitive and resistant to chemotherapy.
Kong F; He S; Shen X; Li L; Fang J; Lian M
Neoplasma; 2020 May; 67(3):473-483. PubMed ID: 32064881
[TBL] [Abstract][Full Text] [Related]
17. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
[TBL] [Abstract][Full Text] [Related]
18. RP11‑156L14.1 regulates SSR1 expression by competitively binding to miR‑548ao‑3p in hypopharyngeal squamous cell carcinoma.
Yan J; Wang ZH; Yan Y; Luo HN; Ren XY; Li N; Zheng GX; Hou J
Oncol Rep; 2020 Nov; 44(5):2080-2092. PubMed ID: 33000261
[TBL] [Abstract][Full Text] [Related]
19. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H
Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
